Squarepoint Ops LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 114 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$212,000
+78.2%
60,513
+411.1%
0.00%
+100.0%
Q3 2018$119,000
+85.9%
11,839
+12.5%
0.00%0.0%
Q1 2018$64,000
-55.2%
10,521
-34.7%
0.00%
-66.7%
Q3 2017$143,000
-47.2%
16,119
-45.2%
0.00%
-72.7%
Q4 2016$271,000
+6.7%
29,433
+50.2%
0.01%
-31.2%
Q2 2016$254,000
-29.6%
19,600
+55.6%
0.02%
-60.0%
Q4 2015$361,000
+76.1%
12,600
+159.3%
0.04%
-79.8%
Q4 2014$205,0004,8590.20%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q4 2014
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders